Skip to main content

Advertisement

Table 2 Cardiac catheterization dataa

From: N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial

  NAC group (n = 45) Placebo group (n = 45) P value
Preprocedural hydration, mL 2254 ± 633 2272 ± 602 0.89
Type of radiocontrast agent    
   Iohexol, n(%) 32(72%) 34(76%) 1.00
   Iodixanol, n(%) 1(2%) 0(0%) 1.00
   Diatrizoate meglumine/sodium, n(%) 0(0%) 1(2%) 0.88
   Diatrizoate meglumine/sodium+Iodixanol, n(%) 1(2%) 1(2%) 1.00
   Diatrizoate meglumine/sodium+Iohexol, n(%) 11(24%) 9(20%) 0.82
Dose of radiocontrast agent    
   Iohexol, mL 100.11 ± 37.80 102.22 ± 40.43 0.37
   Iodixanol, mL 6.11 ± 28.78 1.56 ± 10.43 0.32
   Diatrizoate meglumine/sodium, mL 11.78 ± 20.48 17.33 ± 36.51 0.79
   Total, mL 118.00 ± 35.20 121.11 ± 43.95 0.71
  1. a All plus-minus values are mean ± SD.